173 related articles for article (PubMed ID: 36715848)
1. Incidence of severe hypokalaemia in patients taking indapamide.
Lin Z; Cheung BMY; Tang V; Tsoi MF
Intern Emerg Med; 2023 Mar; 18(2):549-557. PubMed ID: 36715848
[TBL] [Abstract][Full Text] [Related]
2. Hyponatraemia and hypokalaemia due to indapamide.
Chapman MD; Hanrahan R; McEwen J; Marley JE
Med J Aust; 2002 Mar; 176(5):219-21. PubMed ID: 11999238
[TBL] [Abstract][Full Text] [Related]
3. Use of indapamide in hospital and community clinics and its effect on plasma potassium in Chinese patients.
Chang S; Chan WH; Kong Y; Chan GM; Raymond K; Lee A; Lee SC; Critchley JA; Chan JC
J Clin Pharm Ther; 1998 Aug; 23(4):295-302. PubMed ID: 9867313
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of indapamide sustained release 1.5 mg in hypertension.
Donnelly R
Clin Pharmacokinet; 1999; 37 Suppl 1():21-32. PubMed ID: 10491730
[TBL] [Abstract][Full Text] [Related]
5. [Hyponatremia with somnolence due to indapamide].
Hamano T; Yamamoto T; Miyamori I; Kuriyama M
Rinsho Shinkeigaku; 2008 Jan; 48(1):52-5. PubMed ID: 18386633
[TBL] [Abstract][Full Text] [Related]
6. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
Ambrosioni E; Safar M; Degaute JP; Malin PL; MacMahon M; Pujol DR; de Cordoüe A; Guez D
J Hypertens; 1998 Nov; 16(11):1677-84. PubMed ID: 9856369
[TBL] [Abstract][Full Text] [Related]
7. Indapamide sustained release: a review of its use in the treatment of hypertension.
Robinson DM; Wellington K
Drugs; 2006; 66(2):257-71. PubMed ID: 16451099
[TBL] [Abstract][Full Text] [Related]
8. [2 clinical cases of hypopotassemia during treatment with indapamide].
Meregalli M; Bertola G; Torchio G; Bocchia M
Recenti Prog Med; 1989 Feb; 80(2):72-5. PubMed ID: 2711019
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
Chalmers J; Castaigne A; Morgan T; Chastang C
J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
[TBL] [Abstract][Full Text] [Related]
10. [Renaissance of diuretics in the treatment of hypertension].
Hörl WH
Wien Klin Wochenschr; 1999 Nov; 111(21):903-7. PubMed ID: 10599155
[TBL] [Abstract][Full Text] [Related]
11. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
[TBL] [Abstract][Full Text] [Related]
12. Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension.
Matheson AJ; Cheer SM; Goa KL
Drugs; 2001; 61(8):1211-29. PubMed ID: 11465878
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of indapamide 1.5 mg sustained release coated tablets in the therapy of arterial hypertension].
Asmar R
Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):94-104. PubMed ID: 9772936
[TBL] [Abstract][Full Text] [Related]
14. Indapamide-induced severe hyponatremia and hypokalemia.
Chan TY
Ann Pharmacother; 1995 Nov; 29(11):1124-8. PubMed ID: 8573958
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of hypertension with indapamide 1.5 mg sustained-release form: synthesis of results].
Guez D; Mallion JM; Degaute JP; Malini PL; Baldwin R; Rodriguez-Pujol D; de Cordoüe A; Barrandon S; Chastang C; Safar M
Arch Mal Coeur Vaiss; 1996 Sep; 89 Spec No 4():17-25. PubMed ID: 8952810
[TBL] [Abstract][Full Text] [Related]
16. Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes.
Kuo SW; Pei-Dee ; Hung YJ; Hsieh AT; Wu LY; Hsieh CH; He CT; Yang TC; Lian WC
Am J Hypertens; 2003 Aug; 16(8):623-8. PubMed ID: 12878366
[TBL] [Abstract][Full Text] [Related]
17. Hypokalaemia in hypertensive Blacks treated with diuretics.
Schultz EL; Seftel HC
S Afr Med J; 1978 Mar; 53(10):349. PubMed ID: 653467
[No Abstract] [Full Text] [Related]
18. Hyponatraemia and hypokalaemia caused by indapamide.
Howes LG
Med J Aust; 2002 Jul; 177(1):53-4; author reply 54. PubMed ID: 12088485
[No Abstract] [Full Text] [Related]
19. Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy.
Krum H; Skiba M; Gilbert RE
Diabet Med; 2003 Sep; 20(9):708-12. PubMed ID: 12925048
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programme.
Pella D
High Blood Press Cardiovasc Prev; 2011 Sep; 18(3):107-13. PubMed ID: 21950782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
